Ahmadi et al., 2020 - Google Patents
Rubidium-82 generator yield and efficiency for PET perfusion imaging: Comparison of two clinical systemsAhmadi et al., 2020
View HTML- Document ID
- 12018697383977349002
- Author
- Ahmadi A
- Klein R
- Lewin H
- Beanlands R
- DeKemp R
- Publication year
- Publication venue
- Journal of Nuclear Cardiology
External Links
Snippet
Abstract Introduction Strontium-82/Rubidium-82 (82 Sr/82 Rb) generators are used widely for positron emission tomography (PET) imaging of myocardial perfusion. In this study, the 82 Rb isotope yield and production efficiency of two FDA-approved 82 Sr/82 Rb generators …
- 238000003384 imaging method 0 title abstract description 30
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus organic compounds
- A61K51/0493—Steroids, e.g. cholesterol, testosterone
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
- G06F19/34—Computer-assisted medical diagnosis or treatment, e.g. computerised prescription or delivery of medication or diets, computerised local control of medical devices, medical expert systems or telemedicine
- G06F19/3456—Computer-assisted prescription or delivery of medication, e.g. prescription filling or compliance checking
-
- G—PHYSICS
- G21—NUCLEAR PHYSICS; NUCLEAR ENGINEERING
- G21G—CONVERSION OF CHEMICAL ELEMENTS; RADIOACTIVE SOURCES
- G21G1/00—Arrangements for converting chemical elements by electromagnetic radiation, corpuscular radiation or particle bombardment, e.g. producing radioactive isotopes
- G21G1/001—Recovery of specific isotopes from irradiated targets
-
- G—PHYSICS
- G21—NUCLEAR PHYSICS; NUCLEAR ENGINEERING
- G21G—CONVERSION OF CHEMICAL ELEMENTS; RADIOACTIVE SOURCES
- G21G1/00—Arrangements for converting chemical elements by electromagnetic radiation, corpuscular radiation or particle bombardment, e.g. producing radioactive isotopes
- G21G1/0005—Isotope delivery systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
- A61K51/1241—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins
- A61K51/1255—Granulates, agglomerates, microspheres
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Ahmadi et al. | Rubidium-82 generator yield and efficiency for PET perfusion imaging: Comparison of two clinical systems | |
| Stokke et al. | Dosimetry-based treatment planning for molecular radiotherapy: a summary of the 2017 report from the Internal Dosimetry Task Force | |
| Bolch et al. | MIRD pamphlet no. 21: a generalized schema for radiopharmaceutical dosimetry—standardization of nomenclature | |
| Dezarn et al. | Recommendations of the American Association of Physicists in Medicine on dosimetry, imaging, and quality assurance procedures for 90Y microsphere brachytherapy in the treatment of hepatic malignancies | |
| Matthay et al. | Correlation of tumor and whole-body dosimetry with tumor response and toxicity in refractory neuroblastoma treated with 131I-MIBG | |
| Lassmann et al. | The relevance of dosimetry in precision medicine | |
| Hobbs et al. | Redefining relative biological effectiveness in the context of the EQDX formalism: implications for alpha-particle emitter therapy | |
| Hänscheid et al. | Blood dosimetry from a single measurement of the whole body radioiodine retention in patients with differentiated thyroid carcinoma | |
| Kollaard et al. | Review of extremity dosimetry in nuclear medicine | |
| Maioli et al. | Quality control on radiochemical purity in Technetium-99m radiopharmaceuticals labelling: three years of experience on 2280 procedures | |
| Sjögreen-Gleisner et al. | EFOMP policy statement NO. 19: dosimetry in nuclear medicine therapy–molecular radiotherapy | |
| Gear et al. | EANM enabling guide: how to improve the accessibility of clinical dosimetry | |
| Debeljuh et al. | National survey to set diagnostic reference levels in nuclear medicine single photon emission imaging in Croatia | |
| Zimmerman | Current status and future needs for standards of radionuclides used in positron emission tomography | |
| Argyrou et al. | Dosimetry and Therapeutic Ratios for Rhenium‐186 HEDP | |
| Reynolds et al. | Adherence of Tc-99 sestamibi to plastic syringes could complicate efforts in dose reduction in MPI SPECT | |
| Craig et al. | IPEM topical report: current molecular radiotherapy service provision and guidance on the implications of setting up a dosimetry service | |
| Kontogeorgakos et al. | Patient-specific dosimetry calculations using mathematic models of different anatomic sizes during therapy with 111In-DTPA-D-Phe1-octreotide infusions after catheterization of the hepatic artery | |
| Costa et al. | Technologist approach to global dose optimization | |
| Marquis et al. | MIRD Pamphlet No. 29: MIRDy90—A 90Y Research Microsphere Dosimetry Tool | |
| Mat Nawi et al. | 99m Tc-sodium phytate is a valid alternative to the gold-standard 99m Tc-sulfur colloid in the measurement of gastric emptying among healthy multi-ethnic Asian population: results of a randomized cross-over trial | |
| Soulek et al. | Practical considerations for implementation of 177Lu-DOTATATE neuroendocrine tumor treatment programs | |
| Schultz et al. | A performance evaluation of 90Y dose-calibrator measurements in nuclear pharmacies and clinics in the United States | |
| Briat et al. | In vivo assessment of cardiac insulin resistance by nuclear probes using an iodinated tracer of glucose transport | |
| WO2023007256A1 (en) | Improved dosing method for positron emission tomography imaging |